May 18, 2013 10:58 PM ET

Pharmaceuticals

Company Overview of Prestwick Pharmaceuticals, Inc.

Company Overview

Prestwick Pharmaceuticals, Inc. develops and markets therapeutic pharmaceutical drugs for chronic central nervous systems diseases. The company focuses on restless legs syndrome, schizophrenia, autism, Alzheimer’s, and sleep apnea ailments. Prestwick Pharmaceuticals, Inc. was formerly known as KCS Pharmaceuticals, Inc. and changed its name in 2003. The company was incorporated in 2002 and is based in Washington, District Of Columbia. As of September 16, 2008, Prestwick Pharmaceuticals, Inc. operates as a subsidiary of Biovail Corporation.

1825 K Street North West

Suite 1475

Washington, DC 20006

United States

Founded in 2002

29 Employees

Phone:

202-296-1400

Fax:

202-296-7450

Key Executives for Prestwick Pharmaceuticals, Inc.

Executive Chairman
Age: 67
Chief Financial Officer
Age: 64
Chief Medical Officer
Age: 55
Chief Technology Officer and Executive Vice President
Age: 57
Chief Scientific Officer and Head of Development
Age: 51
Compensation as of Fiscal Year 2012.

Similar Private Companies By Industry

Company Name Region
ILN Pharmaceuticals, Inc. United States
VGX Pharmaceuticals, LLC United States
Lifesmart Nutrition Technologies Inc. United States
Symphony Evolution, Inc. United States
Corceuticals, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Prestwick Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.